(Q44019584)

English

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Céline Soudant

object named as

Céline Soudant

3

0 references

Wilfried le Goff

object named as

Wilfried Le Goff

4

0 references

author name string

Maryse Guerin

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pascal Egger

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Arie van Tol

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Reynald Dupuis

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

M John Chapman

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

163

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

287-296

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Lipoprotein of the Density 1. 006–1. 020 in the Plasma of Patients with Type III Hyperlipoproteinaemia in the Postabsorptive State

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Two subpopulations of intermediate density lipoprotein and their relationship to plasma triglyceride and cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Lipoprotein heterogeneity and apolipoprotein B metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Atherogenicity of triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Changes in particle size of high density lipoproteins during incubation with very low density lipoproteins, cholesteryl ester transfer protein and lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

The effect of the HMG-CoA reductase inhibitor simvastatin and of cholestyramine on hepatic apolipoprotein mRNA levels in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900037-0

7 January 2021

Identifiers

10.1016/S0021-9150(02)00037-0

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44019584&oldid=2105693874"